|
Market Closed -
Euronext Paris
12:55:00 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 2.453 EUR | -4.10% |
|
+5.46% | -34.02% |
| 10-08 | Valneva Says UK Revokes Chikungunya Virus Vaccine's Marketing Authorization; Shares Down Pre-Bell | MT |
| 10-08 | Valneva: United Kingdom Withdraws IXCHIQ Authorization |  |
Company Valuation: Valneva SE
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,574 | 861.1 | 655.1 | 351.1 | 642.3 | 465.2 | - | - |
| Change | - | -66.55% | -23.93% | -46.4% | 82.94% | -27.57% | - | - |
| Enterprise Value (EV) 1 | 2,286 | 670.5 | 737.8 | 399.1 | 739.9 | 599.4 | 528.1 | 517.4 |
| Change | - | -70.66% | 10.04% | -45.9% | 85.38% | -19% | -11.9% | -2.01% |
| P/E | -32.7x | -5.02x | -6.47x | -27x | -5.47x | -5.63x | 8.88x | 11.8x |
| PBR | 15.1x | - | 5.1x | 1.94x | 6.07x | 8.67x | 3.65x | 2.68x |
| PEG | - | -0.1x | 0.2x | 0.3x | -0x | 0.2x | -0x | -0.5x |
| Capitalization / Revenue | 7.4x | 2.38x | 4.26x | 2.07x | 3.68x | 3.08x | 1.64x | 1.87x |
| EV / Revenue | 6.57x | 1.86x | 4.8x | 2.35x | 4.24x | 3.97x | 1.86x | 2.08x |
| EV / EBITDA | -48.5x | -9.69x | -11.3x | 12.1x | -12.5x | -17.7x | 5.1x | 9.65x |
| EV / EBIT | -37.2x | -5.91x | -8.99x | 29.9x | -9.12x | -10.3x | 6.84x | 9.66x |
| EV / FCF | -140x | -2.44x | -3.4x | -4.92x | -12.9x | -12.8x | 5.76x | 67.8x |
| FCF Yield | -0.71% | -41% | -29.4% | -20.3% | -7.75% | -7.83% | 17.4% | 1.48% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.75 | -1.24 | -0.73 | -0.08 | -0.68 | -0.4357 | 0.2762 | 0.2083 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 348.1 | 361.3 | 153.7 | 169.6 | 174.7 | 150.8 | 283.3 | 248.3 |
| EBITDA 1 | -47.1 | -69.2 | -65.24 | 32.92 | -59.42 | -33.9 | 103.6 | 53.62 |
| EBIT 1 | -61.4 | -113.4 | -82.09 | 13.33 | -81.16 | -57.97 | 77.2 | 53.56 |
| Net income 1 | -73.4 | -143.3 | -101.4 | -12.25 | -115.2 | -81.35 | 53.02 | 28.71 |
| Net Debt 1 | -288.9 | -190.6 | 82.74 | 48.04 | 97.6 | 134.2 | 62.86 | 52.23 |
| Reference price 2 | 24.500 | 6.224 | 4.720 | 2.162 | 3.718 | 2.453 | 2.453 | 2.453 |
| Nbr of stocks (in thousands) | 105,078 | 138,355 | 138,788 | 162,397 | 172,759 | 189,647 | - | - |
| Announcement Date | 2/3/22 | 3/23/23 | 3/21/24 | 3/20/25 | 3/17/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.63x | 3.97x | -17.68x | - | 519M | |
| 16.87x | 6.34x | 12.15x | 1.77% | 63.77B | |
| 30.14x | 8.25x | 27.02x | 0.04% | 56.37B | |
| 37.48x | 6.65x | 19.86x | 0.86% | 54.62B | |
| 34.85x | 3.31x | 14.29x | -.--% | 44.06B | |
| 48.85x | 5.63x | 30.81x | -.--% | 42.11B | |
| -19.86x | 192.36x | -21.16x | -.--% | 41B | |
| 47.33x | 8.41x | 28.18x | -.--% | 34.92B | |
| 32x | 8.13x | 21.15x | 0.41% | 32.82B | |
| -71.62x | 13.03x | -68.47x | -.--% | 24.7B | |
| Average | 15.04x | 25.61x | 4.61x | 0.34% | 39.49B | |
| Weighted average by Cap. | 21.60x | 26.31x | 11.19x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- VLA Stock
- Valuation Valneva SE
Select your edition
All financial news and data tailored to specific country editions
